However, PR levels can be quite variable even when ER is strongly expressed in breast tumor cells and the expression levels for both ER and PR can vary greatly in a tumor designated “ER/PR positive.” It is possible that differences in levels of ER and PR expression may lead to differential treatment responses and survival outcomes. The gene discussed is ESR1; the disease is neoplasm.